Gelatinase A (MMP-2) is necessary and sufficient for renal tubular cell epithelial-mesenchymal transformation

American Journal of Pathology

Volumn 162, Issue 6, 2003, Pages 1937-1949

  Cheng, Sunfa ^b   Lovett, David H ^a  

^a SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; GELATINASE A; MATRIX METALLOPROTEINASE 14; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATROPHY; BASEMENT MEMBRANE; CELL TRANSFORMATION; CONTROLLED STUDY; EPITHELIUM; GENE REARRANGEMENT; KIDNEY FAILURE; KIDNEY FIBROSIS; KIDNEY TUBULE CELL; MALE; MESENCHYME CELL; MYOFIBROBLAST; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0038582623     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)64327-1     Document Type: Article

References (80)

1. Mackensen-Haen S, Bohle A, Christensen J, Wehrmann M, Kendziorra H, Kokot F: The consequences for renal function of widening of the interstitium ana changes in the tubular epithelium of the renal cortex and outer medulla in various renal diseases. Clin Nephrol 1992, 37:70-77
2. Fine LG, Ong AC, Norman JT: Mechanisms of tubulo-interstitial injury in progressive renal diseases. Eur J Clin Invest 1993, 23:259-265
3. Fine LG, Orphanides C, Norman JT: Progressive renal disease: the chronic hypoxia hypothesis. Kidney Int Suppl 1998, 65:S74-S78
4. Bohle A, von Gise H, Mackensen-Haen S, Stark-Jakob B: The obliteration of the post-glomerular capillaries and its influence upon the function of both glomeruli and tubuli: functional interpretation of morphologic findings. Klin Wochenschr 1981, 59:1043-1051
5. Harris DC, Chan L, Schrier RW: Remnant kidney hypermetabolism and progression of chronic renal failure. Am J Physiol 1988, 254: F267-F276
6. Orphanides C, Fine LG, Norman JT: Hypoxia stimulates proximal tubular cell matrix production via a TGF-β1-independent mechanism. Kidney Int 1997, 52:637-647
7. Falanga V, Martin TA, Takagi H, Kirsner RS, Helfman T, Pardes J, Ochoa MS: Low oxygen tension increases mRNA levels of α 1 (I) procollagen in human dermal fibroblasts. J Cell Physiol 1993, 157: 408-412
8. Agocha A, Lee HW, Eghbali-Webb M: Hypoxia regulates basal and induced DNA synthesis and collagen type I production in human cardiac fibroblasts: effects of transforming growth factor-β1, thyroid hormone, angiotensin II, and basic fibroblast growth factor. J Mol Cell Cardiol 1997, 29:2233-2244
9. Miller RL, Kohan DE: Hypoxia regulates endothelin-1 production by the inner medullary collecting duct. J Lab Clin Med 1998, 131:45-48
10. Alvarez RJ, Sun MJ, Haverty TP, Iozzo RV, Myers JC, Neilson EG: Biosynthetic and proliferative characteristics of tubulointerstitial fibroblasts probed with paracrine cytokines. Kidney Int 1992, 41:14-23
11. Creely JJ, DiMari SJ, Howe AM, Haralson MA: Effects of transforming growth factor-β on collagen synthesis by normal rat kidney epithelial cells. Am J Pathol 1992, 140:45-55
12. Border WA, Noble NA: TGF-β in kidney fibrosis: a target for gene therapy. Kidney Int 1997, 51:1388-1396
13. Border WA, Okuda S, Languino LR, Sporn MB, Ruoslahti E: Suppression of experimental glomerulonephritis by antiserum against transforming growth factor-β 1. Nature 1990, 346:371-374
14. Akagi Y, Isaka Y, Arai M, Kaneko T, Takenaka M, Moriyama T, Kaneda Y, Ando A, Orita Y, Kamada T, Ueda N, Imai E: Inhibition of TGF-β 1 expression by antisense oligonucleotides suppressed extracellular matrix accumulation in experimental glomerulonephritis. Kidney Int 1996, 50:148-155
15. Border WA, Noble NA, Yamamoto T, Harper JR, Yamaguchi Y, Pierschbacher MD, Ruoslahti E: Natural inhibitor of transforming growth factor-β protects against scarring in experimental kidney disease. Nature 1992, 360:361-364
16. Isaka Y, Brees DK, Ikegaya K, Kaneda Y, Imai E, Noble NA, Border WA: Gene therapy by skeletal muscle expression of decorin prevents fibrotic disease in rat kidney. Nat Med 1996, 2:418-423
17. Weber KT: Fibrosis, a common pathway to organ failure: angiotensin II and tissue repair. Semin Nephrol 1997, 17:467-491
18. Goumenos DS, Brown CB, Shortland J, el Nahas AM: Myofibroblasts, predictors of progression of mesangial IgA nephropathy? Nephrol Dial Transplant 1994, 9:1418-1425
19. Roberts IS, Burrows C, Shanks JH, Venning M, McWilliam LJ: Interstitial myofibroblasts: predictors of progression in membranous nephropathy. J Clin Pathol 1997, 50:123-127
20. Alpers CE, Hudkins KL, Gown AM. Johnson RJ: Enhanced expression of "muscle-specific" actin in glomerulonephritis. Kidney Int 1992, 41:1134-1142
21. Alpers CE, Hudkins KL, Floege J, Johnson RJ: Human renal cortical interstitial cells with some features of smooth muscle cells participate in tubulointerstitial and crescentic glomerular injury. J Am Soc Nephrol 1994, 5:201-209
22. MacPherson BR, Leslie KO, Lizaso KV, Schwarz JE: Contractile cells of the kidney in primary glomerular disorders: an immunohistochemical study using an anti-a-smooth muscle actin monoclonal antibody. Hum Pathol 1993, 24:710-716
23. Diamond JR, van Goor H, Ding G, Engelmyer E: Myofibroblasts in experimental hydronephrosis. Am J Pathol 1995, 146:121-129
24. Essawy M, Soylemezoglu O, Muchaneta-Kubara EC, Shortland J, Brown CB, el Nahas AM: Myofibroblasts and the progression of diabetic nephropathy. Nephrol Dial Transplant 1997, 12:43-50
25. Zhang G, Moorhead P, el Nahas A: Myofibroblasts and the progression of experimental glomerulonephritis. Exp Nephrol 1995, 3:308-318
26. Hewitson TD, Becker GJ: Interstitial myofibroblasts in IgA glomerulonephritis. Am J Nephrol 1995, 15:111-117
27. Hewitson TD, Wu HL, Becker GJ: Interstitial myofibroblasts in experimental renal infection and scarring. Am J Nephrol 1995, 15:411-417
28. Johnson RJ, Alpers CE, Yoshimura A, Lombardi D, Pritzl P, Floege J, Schwartz SM: Renal injury from angiotensin II-mediated hypertension. Hypertension 1992, 19:464-474
29. Ng YY, Huang TP, Yang WC, Chen ZP, Yang AH, Mu W, Nikolic Paterson DJ, Atkins RC, Lan HY: Tubular epithelial-myofibroblast transdifferentiation in progressive tubulointerstitial fibrosis in 5/6 nephrectomized rats. Kidney Int 1998, 54:864-876
30. Fan JM, Ng YY, Hill PA, Nikolic-Paterson DJ, Mu W, Atkins RC, Lan HY: Transforming growth factor-β regulates tubular epithelial-myofibroblast transdifferentiation in vitro. Kidney Int 1999, 56:1455-1467
31. Yang J, Liu Y: Dissection of key events in tubular epithelial to myofibroblast transition and its implications in renal interstitial fibrosis. Am J Pathol 2001, 159:1465-1475
32. Kopp JB, Factor VM, Mozes M, Nagy P, Sanderson N, Bottinger EP, Klotman PE, Thorgeirsson. SS: Transgenic mice with increased plasma levels of TGF-β 1 develop progressive renal disease. Lab Invest 1996, 74:991-1003
33. Overall CM, Wrana JL, Sodek J: Transcriptional and post-transcriptional regulation of 72-kDa gelatinase/type IV collagenase by transforming growth factor-β 1 in human fibroblasts: comparisons with collagenase and tissue inhibitor of matrix metalloproteinase gene expression. J Biol Chem 1991, 266:14064-14071
34. Marti HP, Lee L, Kashgarian M, Lovett DH: Transforming growth factor-β 1 stimulates glomerular mesangial cell synthesis of the 72-kd type IV collagenase. Am J Pathol 1994, 144:82-94
35. Zeisberg M, Bonner G, Maeshima Y, Colorado P, Muller GA, Strutz F, Kalluri R: Renal fibrosis: collagen composition and assembly regulates epithelial-mesenchymal transdifferentiation. Am J Pathol 2001, 159:1313-1321
36. Song W, Jackson K, McGuire PG: Degradation of type IV collagen by matrix metalloproteinases is an important step in the epithelial-mesenchymal transformation of the endocardial cushions. Dev Biol 2000, 227:606-617
37. Okada Y, Morodomi T, Enghild JJ, Suzuki K, Yasui A, Nakanishi I, Salvesen G, Nagase H: Matrix metalloproteinase 2 from human rheumatoid synovial fibroblasts: purification and activation of the precursor and enzymic properties. Eur J Biochem 1990, 194:721-730
38. McMillan JI, Riordan JW, Couser WG, Pollock AS, Lovett DH: Characterization of a glomerular epithelial cell metalloproteinase as matrix metalloproteinase-9 with enhanced expression in a model of membranous nephropathy. J Clin Invest 1996, 97:1094-1101
39. Koivunen E, Arap W, Valtanen H, Rainisalo A, Medina OP, Heikkila P, Kantor C, Gahmberg CG, Salo T, Konttinen YT, Sorsa T, Ruoslahti E, Pasqualini R: Tumor targeting with a selective gelatinase inhibitor. Nature Biotechnol 1999, 17:768-774
40. Lee LK, Meyer TW, Pollock AS, Lovett DH: Endothelial cell injury initiates glomerular sclerosis in the rat remnant kidney. J Clin Invest 1995, 96:953-964
41. Turck J, Pollock AS, Lee LK, Marti HP, Lovett DH: Matrix metalloproteinase 2 (gelatinase A) regulates glomerular mesangial cell proliferation and differentiation. J Biol Chem 1996, 271:15074-15083
42. Mertens PR, Harendza S, Pollock AS, Lovett DH: Glomerular mesangial cell-specific transactivation of matrix metalloproteinase 2 transcription is mediated by YB-1. J Biol Chem 1997, 272:22905-22912
43. Suzuki E, Hirata Y, Hayakawa H, Omata M, Kojima M, Kangawa K, Minamino N, Matsuo H: Evidence for C-type natriuretic peptide production in the rat kidney. Biochem Biophys Res Commun 1993, 192:532-538
44. Walker C, Everitt J, Freed JJ, Knudson Jr AG, Whiteley LO: Altered expression of transforming growth factor-α in hereditary rat renal cell carcinoma. Cancer Res 1991, 51:2973-2978
45. Yu M, Sato H, Seiki M, Spiegel S, Thompson EW: Calcium influx inhibits MT1-MMP processing and blocks MMP-2 activation. FEBS Lett 1997, 412:568-572
46. Lehti K, Lohi J, Valtanen H, Keski-Oja J: Proteolytic processing of membrane-type-1 matrix metalloproteinase is associated with gelatinase A activation at the cell surface. Biochem J 1998, 334:345-353
47. Giannelli G, Fransvea E, Marinosci F, Bergamini C, Colucci S, Schiraldi O, Antonaci S: Transforming growth factor-β1 triggers hepatocellular carcinoma invasiveness via α3β1 integrin. Am J Pathol 2002, 161:183-193
48. Powell DW, Mifflin RC, Valentich JD, Crowe SE, Saada JI, West AB: Myofibroblasts: I. paracrine cells important in health and disease. Am J Physiol 1999, 277:C1-C9
49. Gilles C, Polette M, Coraux C, Tournier JM, Meneguzi G, Munaut C, Volders L, Rousselle P, Birembaut P, Foidart JM: Contribution of MT1 -MMP and of human laminin-5 γ2 chain degradation to mammary epithelial cell migration. J Cell Sci 2001, 114:2967-2976
50. Hendrix MJ, Seftor EA, Chu YW, Trevor KT, Seftor RE: Role of intermediate filaments in migration, invasion, and metastasis. Cancer Metastasis Rev 1996, 15:507-525
51. Hendrix MJ, Seftor EA, Seftor RE, Trevor KT: Experimental co-expression of vimentin and keratin intermediate filaments in human breast cancer cells results in phenotypic interconversion and increased invasive behavior. Am J Pathol 1997, 150:483-495
52. Birchmeier C, Birchmeier W, Brand-Saberi B: Epithelial-mesenchymal transitions in cancer progression. Acta Anat (Basel) 1996, 156:217-226
53. Boyer B, Valles AM, Edme N: Induction and regulation of epithelialmesenchymal transitions. Biochem Pharmacol 2000, 60:1091-1099
54. Desmouliere A, Geinoz A, Gabbiani F, Gabbiani G: Transforming growth factor-β 1 induces α-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts. J Cell Biol 1993, 122:103-111
55. Grupp C, Lottermoser J, Cohen DI, Begher M, Franz HE, Muller GA: Transformation of rat inner medullary fibroblasts to myofibroblasts in vitro. Kidney Int 1997, 52:1279-1290
56. Gressner AM: Transdifferentiation of hepatic stellate cells (Ito cells) to myofibroblasts: a key event in hepatic fibrogenesis. Kidney Int Suppl 1996, 54:S39-S45
57. Shi Y, O'Brien Jr JE, Fard A, Zalewski A: Transforming growth factor-β 1 expression and myofibroblast formation during arterial repair. Arterioscler Thromb Vasc Biol 1996, 16:1298-1305
58. Zavadil J, Bitzer M, Liang D, Yang YC, Massimi A, Kneitz S, Piek E, Bottinger EP: Genetic programs of epithelial cell plasticity directed by transforming growth factor-β. Proc Natl Acad Sci USA 2001, 98: 6686-6691
59. Fukai F, Ohtaki M, Fujii N, Yajima H, Ishii T, Nishizawa Y, Miyazaki K, Katayama T: Release of biological activities from quiescent fibronectin by a conformational change and limited proteolysis by matrix metalloproteinases. Biochemistry 1995, 34:11453-11459
60. Giannelli G, Falk-Marzillier J, Schiraldi O, Stetler-Stevenson WG, Quaranta V: Induction of cell migration by matrix metalloprotease-2 cleavage of laminin-5. Science 1997, 277:225-228
61. Sato H, Takino T, Kinoshita T, Imai K, Okada Y, Stetler Stevenson WG, Seilki M: Cell surface binding and activation of gelatinase A induced by expression of membrane-type-1-matrix metalloproteinase (MT1-MMP). FEBS Lett 1996, 385:238-240
62. Imai K, Ohuchi E, Aoki T, Nomura H, Fujii Y, Sato H, Seiki M, Okada Y: Membrane-type matrix metalloproteinase 1 is a gelatinolytic enzyme and is secreted in a complex with tissue inhibitor of metalloproteinases 2. Cancer Res 1996, 56:2707-2710
63. Pei D, Weiss SJ: Transmembrane-deletion mutants of the membrane-type matrix metalloproteinase-1 process progelatinase A and express intrinsic matrix-degrading activity. J Biol Chem 1996, 271: 9135-9140
64. Sato H, Seiki M: Membrane-type matrix metalloproteinases (MT-MMPs) in tumor metastasis. J Biochem (Tokyo) 1996, 119:209-215
65. Ohuchi E, Imai K, Fujii Y, Sato H, Seiki M, Okada Y: Membrane-type 1 matrix metalloproteinase digests interstitial collagens and other extracellular matrix macromolecules. J Biol Chem 1997, 272:2446-2451
66. Koshikawa N, Giannelli G, Cirulli V, Miyazaki K, Quaranta V: Role of cell surface metalloprotease MT1-MMP in epithelial cell migration over laminin-5. J Cell Biol 2000, 148:615-624
67. d'Ortho MP, Will H, Atkinson S, Butler G, Messent A, Gavrilovic J, Smith B, Timpl R, Zardi L, Murphy G: Membrane-type matrix metalloproteinases 1 and 2 exhibit broad-spectrum proteolytic capacities comparable to many matrix metalloproteinases. Eur J Biochem 1997, 250:751-757
68. Kridel SJ, Chen E, Smith JW: A substrate phage enzyme-linked immunosorbent assay to profile panels of proteases. Anal Biochem 2001, 294:176-184
69. Kridel SJ, Chen E, Kotra LP, Howard EW, Mobashery S, Smith JW: Substrate hydrolysis by matrix metalloproteinase-9. J Biol Chem 2001, 276:20572-20578
70. Chen EI, Kridel SJ, Howard EW, Li W, Godzik A, Smith JW: A unique substrate recognition profile for matrix metalloproteinase-2. J Biol Chem 2002, 277:4485-4491
71. Xu J, Rodriguez D, Petitclerc E, Kim JJ, Hangai M, Moon YS, Davis GE, Brooks PC, Yuen SM: Proteolytic exposure of a cryptic site within collagen type IV is required for angiogenesis and tumor growth in vivo. J Cell Biol 2001, 154:1069-1079
72. Lochter A, Galosy S, Muschler J, Freedman N, Werb Z, Bissell MJ: Matrix metalloproteinase stromelysin-1 triggers a cascade of molecular alterations that leads to stable epithelial-to-mesenchymal conversion anda premalignant phenotype in mammary epithelial cells. J Cell Biol 1997, 139:1861-1872
73. Ho AT, Voura EB, Soloway PD, Watson KL, Khokha R: MMP inhibitors augment fibroblast adhesion through stabilization of focal adhesion contacts and up-regulation of cadherin function. J Biol Chem 2001, 276:40215-40224
74. Qin H, Sun Y, Benveniste EN: The transcription factors Spl, Sp3, and AP-2 are required for constitutive matrix metalloproteinase-2 gene expression in astroglioma cells. J Biol Chem 1999, 274:29130-29137
75. Haas TL, Stitelman D, Davis SJ, Apte SS, Madri JA: Egr-1 mediates extracellular matrix-driven transcription of membrane-type 1 matrix metalloproteinase in endothelium. J Biol Chem 1999, 274:22679-22685
76. Botella LM, Sanchez-Elsner T, Rius C, Corbi A, Bernabeu C: Identification of a critical Sp1 site within the endoglin promoter and its involvement in the transforming growth factor-β stimulation. J Biol Chem 2001, 276:34486-34494
77. Poncelet AC, Schnaper HW: Sp1 and Smad proteins cooperate to mediate transforming growth factor-β 1-induced α 2(I) collagen expression in human glomerular mesangial cells. J Biol Chem 2001, 276:6983-6992
78. Feng XH, Lin X, Derynck R: Smad2, Smad3, and Smad4 cooperate with Sp1 to induce p15(Ink4B) transcription in response to TGF-β. EMBO J 2000, 19:5178-5193
79. Ara T, Deyama Y, Yoshimura Y, Higashino F, Shindoh M, Matsumoto A, Fukuda H: Membrane-type 1-matrix metalloproteinase expression is regulated by E-cadherin through the suppression of mitogen-activated protein kinase cascade. Cancer Lett 2000, 157:115-121
80. Morgunova E, Tuuttila A, Bergmann U, Isupov M, Lindqvist Y, Schneider G, Tryggvason K: Structure of human pro-matrix metalloproteinase-2: activation mechanism revealed. Science 1999, 284:1667-1670